LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/08/15 -- GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced initial results from the tudy to nderstand ortality and orbidy in COPD (SUMMIT) for Relvar®/Breo® Ellipta® 10 ...
↧